# Bristol-Myers Squibb Company (BMY.TO): MoatMap facts

As of 27 Oct 2026. Research data, not investment advice.

As of 27 Oct 2026, MoatMap's StockRank for Bristol-Myers Squibb Company (BMY.TO) is 72/100, ranked against 24,000+ stocks in 35 markets (Quality 74, Value 69, Momentum 25, each scored against its sector).

- StockRank: 72/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 74, Value 69, Momentum 25: each a 0-100 percentile within Healthcare.
- Position: #7,427 overall, #756 in Healthcare.
- Listing: Canada, TOR; Healthcare / Drug Manufacturers - General.
- Last close: 22.62 CAD on 26 Oct 2026.
- Insider filings, last 180 days: no director or 5%+ holder trades with a stated value.

Source: https://moatmap.ai/stock/BMY.TO
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker